Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
Status:
Completed
Trial end date:
2019-10-09
Target enrollment:
Participant gender:
Summary
The study is testing a new medicine for weight control in people with overweight or obesity.
The aim of the study is to find out how safe the study medicine is and how it works in the
body. Participants will either get NNC9204-1706 (the new study medicine) or placebo (a dummy
medicine) - which treatment participants get is decided by chance. NNC9204-1706 is a new
medicine which cannot be prescribed by doctors. Participants will get an injection under the
skin of participants' stomach each morning for 10 weeks. A medical tool called NovoPen®4 will
be used for the injection. Participants must change the part of the pen including the
medicine (the cartridge) each day. The study will last for about 16 weeks. Participants will
have at least 17 clinic visits and 10 phone calls with the study doctor. At certain times
during the study, participants will have blood drawn and 3 different kinds of heart tests
(electrocardiograms). Study doctor will ask participants to answer mental health surveys.